| PERIOD ENDING | 18-Nov-09 | 26-Aug-09 | 6-May-09 | 11-Feb-09 | | Total Revenue | 51,718 | 84,217 | 68,999 | 70,700 | | Cost of Revenue | 15,910 | (46,089) | 45,022 | 45,520 | | | Gross Profit | 35,808 | 130,306 | 23,977 | 25,180 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,789 | 132,893 | 20,886 | 19,938 | | Non Recurring | 39 | 19,797 | (97) | 639 | | Others | 3,522 | 5,867 | 4,347 | 4,339 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,853) | (27,427) | (1,159) | 264 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (563) | 954 | (379) | 143 | | Earnings Before Interest And Taxes | (4,105) | (27,297) | (1,538) | 407 | | Interest Expense | 128 | 181 | 66 | 56 | | Income Before Tax | (4,233) | (27,478) | (1,604) | 351 | | Income Tax Expense | (1,367) | (4,226) | (600) | 155 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,866) | (23,252) | (1,004) | 196 | | | Non-recurring Events | | Discontinued Operations | (851) | (67) | (49) | (50) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,717) | (23,319) | (1,053) | 146 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,717) | ($23,319) | ($1,053) | $146 |
|
0.02% Nasdaq 0.00%
Income Statement
